Dysthymic disorder: treatment with citalopram.
Depress Anxiety
; 15(1): 18-22, 2002.
Article
em En
| MEDLINE
| ID: mdl-11816048
ABSTRACT
We studied 15 patients with dysthymic disorder with open-label citalopram. The purpose of this study was to determine the dose range and safety of citalopram necessary for treatment of patients with dysthymic disorder and to attempt to increase doses in order to enhance remission of patients with dysthymic disorder when treated. Citalopram was well tolerated. The mean dose used in this 10-week study was 37.3 mg and the majority of patients responded to treatment. Various criteria for response and remission were employed. These findings are intended to give guidelines for a subsequent treatment study of dysthymic patients with citalopram using a double-blind placebo-controlled strategy.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Citalopram
/
Guias como Assunto
/
Antidepressivos de Segunda Geração
/
Transtorno Distímico
Tipo de estudo:
Clinical_trials
/
Diagnostic_studies
/
Guideline
/
Qualitative_research
Limite:
Adult
/
Female
/
Humans
/
Male
Idioma:
En
Revista:
Depress Anxiety
Assunto da revista:
PSIQUIATRIA
Ano de publicação:
2002
Tipo de documento:
Article
País de afiliação:
Estados Unidos